Any questions? Contact us+49 761-389 49-0

Seraseq™ Tri-Level Tumor Mutation DNA Mix v2 HC

Seraseq™ Tri-Level Tumor Mutation DNA Mix v2 HC

Seraseq™ Tri-Level Tumor Mutation DNA Mix v2 HC

#0710-0097 Aa multiplexed mixture of actionable biosynthetic DNA targets precisely blended with a single, well-characterized genomic background.
€2,410.00 *

Prices plus VAT plus shipping costs

Delivery time 7 Workdays

Size: 1 x 25 µl (25 ng/µl)
  • 0710-0097
Single-sample format for daily run use, 40 unique multiplexed variants across 28 genes at allele... more
Single-sample format for daily run use, 40 unique multiplexed variants across 28 genes at allele frequencies distributed at 4%, 7% or 10%, 20 SNVs, 5 SNVs that are part of homopolymers, 13 indels, 2 SVs. Mutation targets quantitated with digital PCR, well-characterized GM24385 human genomic DNA as background ‘wild-type’ material. Manufactured under cGMP within ISO 9001 and ISO 13485 certified facilities. The Seraseq Tumor Mutation DNA Mix v2 (AF7) HC is formulated for use with targeted next-generation sequencing (NGS) assays that detect mutations in key oncogenes and tumor suppressor genes. The Seraseq Tumor Mutation DNA Mix v2 (AF7) HC is intended as a quality reference material for translational and disease research testing to monitor library preparation, sequencing, and variant allele detection under a given set of bioinformatics pipeline parameters.

For details click here.
PROPERTIES
storage temperature: -20°
shipping method: dry ice
regulatory status: RUO
Viewed